APP Receives Two FDA Approvals For Fludarabine Phosphate (PharmaceuticalOnline)
Abraxis Pharmaceutical Products (APP), the hospital-based business of Abraxis BioScience, Inc., recently announced two approvals from U.S. Food and Drug Administration (FDA) to market the liquid and lyophilized versions of Fludarabine phosphate. The lyophilized version of fludarabine, which is the generic equivalent of Fludara (fludarabine phosphate) for injection distributed by Bayer HealthCare ...

FDA Approves Chemotherapy Drug Ixempra For Advanced Breast Cancer (Medical News Today)
The US Food and Drug Administration (FDA) has approved a new chemotherapy drug called Ixempra (ixabepilone) for the treatment of advanced breast cancer.The announcement was made to the press by Bristol-Myers Squibb on 17th October, the maker of the new drug, who also said the drug will be available "within days". [click link for full article]